Time to define the disorders of the syndrome of COPD

被引：45

作者：

Beasley, Richard ^{[1
,2
]}

Weatherall, Mark ^{[2
,3
]}

Travers, Justin ^{[1
]}

Shirtcliffe, Philippa ^{[1
,2
]}

机构：

[1] Med Res Inst New Zealand, Wellington 6143, New Zealand

[2] Capital & Coast Dist Hlth Board, Wellington, New Zealand

[3] Univ Otago, Wellington, New Zealand

来源：

关键词：

D O I：

10.1016/S0140-6736(09)61541-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：670 / 672

页数：3

共 14 条

[1] [Anonymous], 2006, LANCET, V368, P705
[2] [Anonymous], TREATING INDIVIDUALS
[3] Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial
Brightling, CE
Monteiro, W
Ward, R
Parker, D
Morgan, MDL
Wardlaw, AJ
Pavord, ID
[J]. LANCET, 2000, 356 (9240) : 1480 - 1485
[4] What have we learned from large drug treatment trials in COPD?
Calverley, Peter M. A.
Rennard, Stephen I.
[J]. LANCET, 2007, 370 (9589) : 774 - 785
[5] Bronchodilator reversibility testing in chronic obstructive pulmonary disease
Calverley, PMA
Burge, PS
Spencer, S
Anderson, JA
Jones, PW
[J]. THORAX, 2003, 58 (08) : 659 - 664
[6] From COPD to chronic systemic inflammatory syndrome?
Fabbri, Leonardo M.
Rabe, Klaus F.
[J]. LANCET, 2007, 370 (9589) : 797 - 799
[7] Fishman A, 2003, NEW ENGL J MED, V348, P2059
[8] Global Initiative for Asthma, 2008, GLOB STRAT ASTHM MAN
[9] Global Strategy for the Diagnosis Management and Prevention of COPD, 2008, GLOB STRAT DIAGN MAN
[10] Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease
Lapperre, TS
Snoeck-Stroband, JB
Gosman, MME
Stolk, J
Sont, JK
Jansen, DF
Kerstjens, HAM
Postma, DS
Sterk, PJ
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (05) : 499 - 504